Heart, Lung and Circulation
Volume 16, Supplement 2 , Pages S5-S6, 2007

Endeavor II Three-Year Clinical Results: A Randomised, Double-Blind, Multicentre Trial of the Endeavor Zotarolimus-Eluting Stent for Treatment of Native Coronary Arteries

  • I. Meredith

      Affiliations

    • Monash Cardiovascular Research Centre, MonashHeart, Southern Health and Monash University, Melbourne, Australia
    • Corresponding Author InformationCorresponding author.
    • ,
  • John Ormiston

      Affiliations

    • Auckland and Mercy Hospital, Auckland, New Zealand
    • ,
  • W. Wijns

      Affiliations

    • Cardiovascular Centre, Aalst, Belgium
    • ,
  • J. Fajadet

      Affiliations

    • Clinique Pasteur, Toulouse, France
    • ,
  • R. Kuntz

      Affiliations

    • Harvard Medical School, Boston, USA
    • ,
  • on behalf of Endeavor II investigators

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1443-9506(07)00285-5

doi:10.1016/j.hlc.2007.06.016

Heart, Lung and Circulation
Volume 16, Supplement 2 , Pages S5-S6, 2007

Article Tools